Search Results - "Pesch, Vincent"

Exosomal profiling should be used to monitor disease activity in MS patients: No by Deltombe, Matthieu, van Pesch, Vincent

Get full text

Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study by Maggi, Pietro, Sati, Pascal, Nair, Govind, Cortese, Irene C. M., Jacobson, Steven, Smith, Bryan R., Nath, Avindra, Ohayon, Joan, Pesch, Vincent, Perrotta, Gaetano, Pot, Caroline, Théaudin, Marie, Martinelli, Vittorio, Scotti, Roberta, Wu, Tianxia, Du Pasquier, Renaud, Calabresi, Peter A., Filippi, Massimo, Reich, Daniel S., Absinta, Martina

“…In multiple sclerosis (MS), a subset of chronic active white matter lesions are identifiable on magnetic resonance imaging by their paramagnetic rims, and…”
Get full text

Immune-mediated neurological syndromes in SARS-CoV-2-infected patients by Guilmot, Antoine, Maldonado Slootjes, Sofia, Sellimi, Amina, Bronchain, Maroussia, Hanseeuw, Bernard, Belkhir, Leila, Yombi, Jean Cyr, De Greef, Julien, Pothen, Lucie, Yildiz, Halil, Duprez, Thierry, Fillée, Catherine, Anantharajah, Ahalieyah, Capes, Antoine, Hantson, Philippe, Jacquerye, Philippe, Raymackers, Jean-Marc, London, Frederic, El Sankari, Souraya, Ivanoiu, Adrian, Maggi, Pietro, van Pesch, Vincent

“…Background Evidence of immune-mediated neurological syndromes associated with the severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection is…”
Get full text

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis by Kalincik, Tomas, Kubala Havrdova, Eva, Horakova, Dana, Izquierdo, Guillermo, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Onofrj, Marco, Lugaresi, Alessandra, Ozakbas, Serkan, Kappos, Ludwig, Kuhle, Jens, Terzi, Murat, Lechner-Scott, Jeannette, Boz, Cavit, Grand'Maison, Francois, Prevost, Julie, Sola, Patrizia, Ferraro, Diana, Granella, Franco, Trojano, Maria, Bergamaschi, Roberto, Pucci, Eugenio, Turkoglu, Recai, McCombe, Pamela A, Pesch, Vincent Van, Van Wijmeersch, Bart, Solaro, Claudio, Ramo-Tello, Cristina, Slee, Mark, Alroughani, Raed, Yamout, Bassem, Shaygannejad, Vahid, Spitaleri, Daniele, Sánchez-Menoyo, José Luis, Ampapa, Radek, Hodgkinson, Suzanne, Karabudak, Rana, Butler, Ernest, Vucic, Steve, Jokubaitis, Vilija, Spelman, Tim, Butzkueven, Helmut

“…ObjectiveOral immunotherapies have become a standard treatment in relapsing-remitting multiple sclerosis. Direct comparison of their effect on relapse and…”
Get full text

IL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy by Muls, Nathalie, Nasr, Zakia, Dang, Hong Anh, Sindic, Christian, van Pesch, Vincent

“…Multiple sclerosis (MS) is thought to be a Th17-mediated dysimmune disease of the central nervous system. However, recent publications have questioned the…”
Get full text

Cutaneous diseases related to a hyperactive T-cell response in ocrelizumab-treated multiple sclerosis patients by Sankari, Souraya El, Van Essche, Cyril, van Pesch, Vincent

Get full text

Prophylactic treatment against GM‐CSF, but not IL‐17, abolishes relapses in a chronic murine model of multiple sclerosis by Uyttenhove, Catherine, Gaignage, Mélanie, Donckers, Dominique, Nasr, Zakia, Cheou, Pamela, Snick, Jacques, D'Auria, Ludovic, Pesch, Vincent

“…The pathogenic role of IL‐17 and GM‐CSF has been unravelled in experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis (MS)…”
Get full text

The central vein sign in multiple sclerosis patients with vascular comorbidities by Guisset, François, Lolli, Valentina, Bugli, Céline, Perrotta, Gaetano, Absil, Julie, Dachy, Bernard, Pot, Caroline, Théaudin, Marie, Pasi, Marco, van Pesch, Vincent, Maggi, Pietro

“…Background: The central vein sign (CVS) is an imaging biomarker able to differentiate multiple sclerosis (MS) from other conditions causing similar appearance…”
Get full text

Enlarged perivascular spaces are associated with brain microangiopathy and aging in multiple sclerosis by Borrelli, Serena, Guisset, François, Vanden Bulcke, Colin, Stölting, Anna, Bugli, Céline, Lolli, Valentina, Du Pasquier, Renaud, van Pesch, Vincent, Absinta, Martina, Pasi, Marco, Maggi, Pietro

“…Background: Growing evidence links brain-MRI enlarged perivascular spaces (EPVS) and multiple sclerosis (MS), but their role remains unclear. Objective: This…”
Get full text

Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis by Diouf, Ibrahima, Malpas, Charles B., Sharmin, Sifat, Roos, Izanne, Horakova, Dana, Havrdova, Eva Kubala, Patti, Francesco, Shaygannejad, Vahid, Ozakbas, Serkan, Izquierdo, Guillermo, Eichau, Sara, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Hamdy, Sherif, Sola, Patrizia, Ferraro, Diana, Grammond, Pierre, Turkoglu, Recai, Buzzard, Katherine, Skibina, Olga, Yamout, Bassem, Altintas, Ayse, Gerlach, Oliver, Pesch, Vincent, Blanco, Yolanda, Maimone, Davide, Lechner‐Scott, Jeannette, Bergamaschi, Roberto, Karabudak, Rana, Iuliano, Gerardo, McGuigan, Chris, Cartechini, Elisabetta, Barnett, Michael, Hughes, Stella, Sa, Maria José, Solaro, Claudio, Kappos, Ludwig, Ramo‐Tello, Cristina, Cristiano, Edgardo, Hodgkinson, Suzanne, Spitaleri, Daniele, Soysal, Aysun, Petersen, Thor, Slee, Mark, Butler, Ernest, Granella, Franco, Gans, Koen, McCombe, Pamela, Ampapa, Radek, Van Wijmeersch, Bart, Walt, Anneke, Butzkueven, Helmut, Prevost, Julie, Sinnige, L. G. F., Sanchez‐Menoyo, Jose Luis, Vucic, Steve, Laureys, Guy, Van Hijfte, Liesbeth, Khurana, Dheeraj, Macdonell, Richard, Gouider, Riadh, Castillo‐Triviño, Tamara, Gray, Orla, Aguera‐Morales, Eduardo, Al‐Asmi, Abdullah, Shaw, Cameron, Deri, Norma, Al‐Harbi, Talal, Fragoso, Yara, Csepany, Tunde, Perez Sempere, Angel, Trevino‐Frenk, Irene, Schepel, Jan, Moore, Fraser, Kalincik, Tomas

“…Background and purpose This study assessed the effect of patient characteristics on the response to disease‐modifying therapy (DMT) in multiple sclerosis (MS)…”
Get full text

International consensus on quality standards for brain health-focused care in multiple sclerosis by Hobart, Jeremy, Bowen, Amy, Pepper, George, Crofts, Harriet, Eberhard, Lucy, Berger, Thomas, Boyko, Alexey, Boz, Cavit, Butzkueven, Helmut, Celius, Elisabeth Gulowsen, Drulovic, Jelena, Flores, José, Horáková, Dana, Lebrun-Frénay, Christine, Marrie, Ruth Ann, Overell, James, Piehl, Fredrik, Rasmussen, Peter Vestergaard, Sá, Maria José, Sîrbu, Carmen-Adella, Skromne, Eli, Torkildsen, Øivind, van Pesch, Vincent, Vollmer, Timothy, Zakaria, Magd, Ziemssen, Tjalf, Giovannoni, Gavin

“…Background: Time matters in multiple sclerosis (MS). Irreversible neural damage and cell loss occur from disease onset. The MS community has endorsed a…”
Get full text

Mechanism of Cellular Formation and In Vivo Seeding Effects of Hexameric β-Amyloid Assemblies by Vrancx, Céline, Vadukul, Devkee M., Suelves, Nuria, Contino, Sabrina, D’Auria, Ludovic, Perrin, Florian, van Pesch, Vincent, Hanseeuw, Bernard, Quinton, Loïc, Kienlen-Campard, Pascal

“…The β-amyloid peptide (Aβ) is found as amyloid fibrils in senile plaques, a typical hallmark of Alzheimer’s disease (AD). However, intermediate soluble…”
Get full text

Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry by Spelman, Tim, Ozakbas, Serkan, Alroughani, Raed, Terzi, Murat, Hodgkinson, Suzanne, Laureys, Guy, Kalincik, Tomas, Van Der Walt, Anneke, Yamout, Bassem, Lechner-Scott, Jeannette, Soysal, Aysun, Kuhle, Jens, Sanchez-Menoyo, Jose Luis, Blanco Morgado, Yolanda, Spitaleri, Daniele LA, van Pesch, Vincent, Horakova, Dana, Ampapa, Radek, Patti, Francesco, Macdonell, Richard, Al-Asmi, Abdullah, Gerlach, Oliver, Oh, Jiwon, Altintas, Ayse, Tundia, Namita, Wong, Schiffon L, Butzkueven, Helmut

“…Background: Effectiveness of cladribine tablets, an oral disease-modifying treatment (DMT) for multiple sclerosis (MS), was established in clinical trials and…”
Get full text

Prediction of relapse activity when switching to cladribine for multiple sclerosis by Zhong, Michael, van der Walt, Anneke, Monif, Mastura, Hodgkinson, Suzanne, Eichau, Sara, Kalincik, Tomas, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, Van Pesch, Vincent, Butler, Ernest, Prevost, Julie, Girard, Marc, Oh, Jiwon, Butzkueven, Helmut, Jokubaitis, Vilija

“…Background: Patients with relapsing–remitting multiple sclerosis commonly switch between disease-modifying therapies (DMTs). Identifying predictors of relapse…”
Get full text

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis by Tao, Chunrong, Simpson, Steve, van der Mei, Ingrid, Blizzard, Leigh, Havrdova, Eva, Horakova, Dana, Shaygannejad, Vahid, Lugaresi, Alessandra, Izquierdo, Guillermo, Trojano, Maria, Duquette, Pierre, Girard, Marc, Grand'Maison, Franois, Grammond, Pierre, Alroughani, Raed, Terzi, Murat, Oreja-Guevara, Celia, Sajedi, Seyed Aidin, Iuliano, Gerardo, Sola, Patrizia, Lechner-Scott, Jeannette, Pesch, Vincent Van, Pucci, Eugenio, Bergamaschi, Roberto, Barnett, Michael, Ramo, Cristina, Singhal, Bhim, LA Spitaleri, Daniele, Slee, Mark, Verheul, Freek, Fernández Bolaños, Ricardo, Amato, Maria Pia, Cristiano, Edgardo, Granella, Franco, Hodgkinson, Suzanne, Fiol, Marcela, Gray, Orla, McCombe, Pamela, Saladino, Maria Laura, Sánchez Menoyo, José Luis, Shuey, Neil, Vucic, Steve, Shaw, Cameron, Deri, Norma, Arruda, Walter Oleschko, Butzkueven, Helmut, Spelman, Tim, Taylor, Bruce V

“…BackgroundAge at onset (AAO) in multiple sclerosis (MS) is an important marker of disease severity and may have prognostic significance. Understanding what…”
Get full text

Confirmed disability progression as a marker of permanent disability in multiple sclerosis by Sharmin, Sifat, Bovis, Francesca, Malpas, Charles, Horakova, Dana, Havrdova, Eva Kubala, Izquierdo, Guillermo, Eichau, Sara, Trojano, Maria, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Onofrj, Marco, Lugaresi, Alessandra, Grand'Maison, Francois, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Terzi, Murat, Gerlach, Oliver, Alroughani, Raed, Boz, Cavit, Shaygannejad, Vahid, Pesch, Vincent, Cartechini, Elisabetta, Kappos, Ludwig, Lechner‐Scott, Jeannette, Bergamaschi, Roberto, Turkoglu, Recai, Solaro, Claudio, Iuliano, Gerardo, Granella, Franco, Wijmeersch, Bart, Spitaleri, Daniele, Slee, Mark, McCombe, Pamela, Prevost, Julie, Ampapa, Radek, Ozakbas, Serkan, Sanchez‐Menoyo, Jose Luis, Soysal, Aysun, Vucic, Steve, Petersen, Thor, Gans, Koen, Butler, Ernest, Hodgkinson, Suzanne, Sidhom, Youssef, Gouider, Riadh, Cristiano, Edgardo, Castillo‐Triviño, Tamara, Saladino, Maria Laura, Barnett, Michael, Moore, Fraser, Rozsa, Csilla, Yamout, Bassem, Skibina, Olga, Walt, Anneke, Buzzard, Katherine, Gray, Orla, Hughes, Stella, Sempere, Angel Perez, Singhal, Bhim, Fragoso, Yara, Shaw, Cameron, Kermode, Allan, Taylor, Bruce, Simo, Magdolna, Shuey, Neil, Al‐Harbi, Talal, Macdonell, Richard, Dominguez, Jose Andres, Csepany, Tunde, Sirbu, Carmen Adella, Sormani, Maria Pia, Butzkueven, Helmut, Kalincik, Tomas

“…Background and purpose The prevention of disability over the long term is the main treatment goal in multiple sclerosis (MS); however, randomized clinical…”
Get full text

Simultaneous bilateral optic neuropathy and myelitis revealing paraneoplastic neurological syndrome associated with multiple onconeuronal antibodies by Carette, Timothée, Mulquin, Nicolas, van Pesch, Vincent, London, Frédéric

“…Paraneoplastic neurological syndromes (PNS) are immune-mediated complications of cancer associated with a broad spectrum of clinical manifestations. Optic…”
Get full text

Prediction of multiple sclerosis outcomes when switching to ocrelizumab by Zhong, Michael, van der Walt, Anneke, Stankovich, Jim, Kalincik, Tomas, Buzzard, Katherine, Skibina, Olga, Boz, Cavit, Hodgkinson, Suzanne, Slee, Mark, Lechner-Scott, Jeannette, Macdonell, Richard, Prevost, Julie, Kuhle, Jens, Laureys, Guy, Van Hijfte, Liesbeth, Alroughani, Raed, Kermode, Allan G, Butler, Ernest, Barnett, Michael, Eichau, Sara, van Pesch, Vincent, Grammond, Pierre, McCombe, Pamela, Karabudak, Rana, Duquette, Pierre, Girard, Marc, Taylor, Bruce, Yeh, Wei, Monif, Mastura, Gresle, Melissa, Butzkueven, Helmut, Jokubaitis, Vilija G

“…Background: Increasingly, people with relapsing-remitting multiple sclerosis (RRMS) are switched to highly effective disease-modifying therapies (DMTs) such as…”
Get full text

Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis by Perdaens, Océane, van Pesch, Vincent

“…Aging is characterized, amongst other features, by a complex process of cellular senescence involving both innate and adaptive immunity, called…”
Get full text

A Role for GDNF and Soluble APP as Biomarkers of Amyotrophic Lateral Sclerosis Pathophysiology by Stanga, Serena, Brambilla, Liliana, Tasiaux, Bernadette, Dang, Anh H, Ivanoiu, Adrian, Octave, Jean-Noël, Rossi, Daniela, van Pesch, Vincent, Kienlen-Campard, Pascal

“…The current inability of clinical criteria to accurately identify the "at-risk group" for Amyotrophic Lateral Sclerosis (ALS) development as well as its…”
Get full text